Originally posted by krobison
View Post
Unconfigured Ad
Collapse
X
-
There are comparative assemblers / scaffolders as part of the AMOS suite.
Do you have a link for "Manuve"? I can't find it
Leave a comment:
-
thank you for your reply. your idea is useful to me and i will try. in fact i have used Manuve to do the job, but the Manuve come across some trouble and i can not solve them, so i hope change a new software.
Leave a comment:
-
I'd recommend searching the forum in addition to below
the only way to be certain of contig order is to have the whole genome sequenced and a total number of contigs equal to the number of chromosomes+plasmids in your organism!
Other than that, you can predict scaffolds based on blasting all your contigs against the "nr" database, finding the typically most closely related organism, then blasting all contigs against ONLY that organism.
Then play around with contig order to minimize the number of genomic inversions and other changes at the ends of contigs and arrange them using a tool like ACT. You can use this information to predict which primer pairs you need for gap closure. If things are ambiguous, try multiple different contig orders and/or skip over a contig in the middle to determine contigs that flank the ambiguously placed contig (which could be a duplicate).
There may be an automated way to do the ACT-like step, but I'm personally not aware of it.
Leave a comment:
-
Moved to a more appropriate forum. Also, this question has been asked multiple times, please search the forums...
Leave a comment:
-
how to order the contigs
when I sequence a genome de nove sequencing, how can I certain the sequence of the contigs, For example, there are contig A, contig B, contig C and how can I know which contig is in the front of others, which is the second and who is the last one?
I know maybe the software of Manuve can do this. Is there any other software can do this too?
Thank you!Tags: None
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: